DOSAGE AND ADMINISTRATION : DOSAGE FORMS AND STRENGTHS : Solution for subcutaneous injection, pre-filled, multi-dose pen that delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg (6 mg/mL, 3 mL) CONTRAINDICATIONS : Do not use in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2
10.1016/S0140-6736(10)60590-9 45
Stay hydrated Dehydration can worsen fatigue, nausea, and constipation on GLP-1 medications
In fact, there can even be some variance in different batches between the specific gauge, though the length is set for the purposes of subcutaneous automatic injection
Considerations for Employers For employers, these results highlight that decisions about GLP-1 coverage extend beyond short-term drug expenses